1. Home
  2. NXST vs ADPT Comparison

NXST vs ADPT Comparison

Compare NXST & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexstar Media Group Inc.

NXST

Nexstar Media Group Inc.

HOLD

Current Price

$166.58

Market Cap

5.0B

Sector

Industrials

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$24.84

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXST
ADPT
Founded
1996
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.5B
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
NXST
ADPT
Price
$166.58
$24.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
9
Target Price
★ $246.75
$29.81
AVG Volume (30 Days)
276.7K
★ 2.0M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
★ 4.51%
N/A
EPS Growth
N/A
★ 63.89
EPS
★ 8.71
N/A
Revenue
★ $4,949,000,000.00
$276,976,000.00
Revenue This Year
$57.64
$5.94
Revenue Next Year
N/A
$22.42
P/E Ratio
$18.94
★ N/A
Revenue Growth
N/A
★ 54.77
52 Week Low
$153.17
$12.00
52 Week High
$254.30
$30.74

Technical Indicators

Market Signals
Indicator
NXST
ADPT
Relative Strength Index (RSI) 55.01 43.60
Support Level $154.26 $23.73
Resistance Level $171.53 $26.51
Average True Range (ATR) 4.45 1.51
MACD 1.54 -0.30
Stochastic Oscillator 88.90 14.80

Price Performance

Historical Comparison
NXST
ADPT

About NXST Nexstar Media Group Inc.

Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Assuming its merger with Tegna is affirmed Nexstar's station total would exceed 259 and reach 80% of the US population. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: